PROFUSA, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PROFUSA, INC. (PFSA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 787.62 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-19
- PROFUSA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 15.79M shares, a 4953.15% increase year-over-year.
- PROFUSA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 19.10M shares, a 1758.17% increase year-over-year.
- PROFUSA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 17.40M shares.
- PROFUSA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 312.48K shares, a 98.20% decline year-over-year.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 787.62K shares 10-Q · filed 2026-08-19 | |||||||
| 2026-03-31 | 15.79M shares 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | 1.94M shares S-1/A · filed 2026-05-01 | |||||||
| 2025-09-30 | 19.10M shares 10-Q · filed 2025-11-19 | 19.10M shares 10-Q · filed 2025-11-19 | ||||||
| 2025-06-30 | 17.40M shares 10-Q · filed 2025-08-14 | 2.99K shares 10-Q · filed 2026-08-19 | 17.40M shares 10-Q · filed 2025-08-14 | |||||
| 2025-03-31 | 312.48K shares 10-Q · filed 2026-05-15 | 17.40M shares 10-Q · filed 2025-06-13 | ||||||
| 2024-12-31 | 111.59K shares S-1/A · filed 2026-05-01 | 17.40M shares 10-K · filed 2025-03-31 | ||||||
| 2024-09-30 | 1.03M shares 10-Q · filed 2025-11-19 | 1.03M shares 10-Q · filed 2025-11-19 | 17.40M shares 10-Q · filed 2024-12-17 | |||||
| 2024-06-30 | 17.40M shares 10-Q · filed 2024-11-15 | |||||||
| 2024-03-31 | 17.40M shares 10-Q · filed 2024-10-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |